Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · IEX Real-Time Price · USD
2.770
+0.030 (1.09%)
At close: Mar 28, 2024, 4:00 PM
2.720
-0.050 (-1.81%)
After-hours: Mar 28, 2024, 4:12 PM EDT

Total Valuation

HRTX has a market cap or net worth of $411.90 million. The enterprise value is $511.12 million.

Market Cap 411.90M
Enterprise Value 511.12M

Important Dates

The last earnings date was Tuesday, March 12, 2024, after market close.

Earnings Date Mar 12, 2024
Ex-Dividend Date n/a

Share Statistics

HRTX has 150.33 million shares outstanding. The number of shares has increased by 26.87% in one year.

Shares Outstanding 150.33M
Shares Change (YoY) +26.87%
Shares Change (QoQ) +4.35%
Owned by Insiders (%) 0.89%
Owned by Institutions (%) 76.09%
Float 122.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.24
Forward PS 2.87
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.02
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.37

Current Ratio 2.37
Quick Ratio 1.76
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -218.36

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -50.60%
Return on Capital (ROIC) -75.94%
Revenue Per Employee $1.01M
Profits Per Employee -$877,452
Employee Count 126
Asset Turnover 0.58
Inventory Turnover 1.35

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +70.50% in the last 52 weeks. The beta is 1.68, so HRTX's price volatility has been higher than the market average.

Beta (1Y) 1.68
52-Week Price Change +70.50%
50-Day Moving Average 2.62
200-Day Moving Average 1.64
Relative Strength Index (RSI) 49.79
Average Volume (30 Days) 3,089,300

Short Selling Information

The latest short interest is 25.43 million, so 16.91% of the outstanding shares have been sold short.

Short Interest 25.43M
Short Previous Month 24.53M
Short % of Shares Out 16.91%
Short % of Float 20.83%
Short Ratio (days to cover) 8.61

Income Statement

In the last 12 months, HRTX had revenue of $127.04 million and -$110.56 million in losses. Loss per share was -$0.80.

Revenue 127.04M
Gross Profit 61.94M
Operating Income -110.62M
Pretax Income -110.56M
Net Income -110.56M
EBITDA -107.16M
EBIT -110.06M
Loss Per Share -$0.80
Full Income Statement

Balance Sheet

The company has $80.41 million in cash and $179.63 million in debt, giving a net cash position of -$99.22 million or -$0.66 per share.

Cash & Cash Equivalents 80.41M
Total Debt 179.63M
Net Cash -99.22M
Net Cash Per Share -$0.66
Equity / Book Value -33.97M
Book Value Per Share -0.23
Working Capital 109.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$58.79 million and capital expenditures -$1.53 million, giving a free cash flow of -$60.32 million.

Operating Cash Flow -58.79M
Capital Expenditures -1.53M
Free Cash Flow -60.32M
FCF Per Share -$0.44
Full Cash Flow Statement

Margins

Gross margin is 48.75%, with operating and profit margins of -87.07% and -87.02%.

Gross Margin 48.75%
Operating Margin -87.07%
Pretax Margin -87.02%
Profit Margin -87.02%
EBITDA Margin -84.35%
EBIT Margin -86.63%
FCF Margin -47.48%

Dividends & Yields

HRTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -26.87%
Shareholder Yield -26.87%
Earnings Yield -26.84%
FCF Yield -14.64%

Analyst Forecast

The average price target for HRTX is $5.00, which is 80.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.00
Price Target Difference 80.51%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 20.97%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 13, 2014. It was a reverse split with a ratio of 1:20.

Last Split Date Jan 13, 2014
Split Type Reverse
Split Ratio 1:20

Scores

HRTX has an Altman Z-Score of -11.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -11.5
Piotroski F-Score 2